These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 21449214

  • 41. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K, Ferdous T, Itashiki Y, Takii M, Mano T, Mori Y, Ueyama Y.
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [Abstract] [Full Text] [Related]

  • 42. Honokiol regulates ovarian cancer cell malignant behavior through YAP/TAZ pathway modulation.
    Liu F, Zhang Y, Xia X, Han J, Cao L.
    J Obstet Gynaecol Res; 2024 Jun; 50(6):1010-1019. PubMed ID: 38576101
    [Abstract] [Full Text] [Related]

  • 43. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
    Iwase M, Yoshiba S, Uchid M, Takaoka S, Kurihara Y, Ito D, Hatori M, Shintani S.
    Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
    [Abstract] [Full Text] [Related]

  • 44. Honokiol targets mitochondria to halt cancer progression and metastasis.
    Pan J, Lee Y, Wang Y, You M.
    Mol Nutr Food Res; 2016 Jun; 60(6):1383-95. PubMed ID: 27276215
    [Abstract] [Full Text] [Related]

  • 45. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
    Zhou C, Guo C, Li W, Zhao J, Yang Q, Tan T, Wan Z, Dong J, Song X, Gong T.
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
    [Abstract] [Full Text] [Related]

  • 46. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
    Godugu C, Doddapaneni R, Singh M.
    Colloids Surf B Biointerfaces; 2017 May 01; 153():208-219. PubMed ID: 28249200
    [Abstract] [Full Text] [Related]

  • 47. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
    Chilampalli C, Guillermo R, Kaushik RS, Young A, Chandrasekher G, Fahmy H, Dwivedi C.
    Exp Biol Med (Maywood); 2011 Nov 01; 236(11):1351-9. PubMed ID: 21908486
    [Abstract] [Full Text] [Related]

  • 48. Honokiol inhibits hepatoma carcinoma cell migration through downregulated Cyclophilin B expression.
    Lee YS, Jeong S, Kim KY, Yoon JS, Kim S, Yoon KS, Ha J, Kang I, Choe W.
    Biochem Biophys Res Commun; 2021 May 07; 552():44-51. PubMed ID: 33743348
    [Abstract] [Full Text] [Related]

  • 49. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.
    Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X.
    World J Gastroenterol; 2004 Dec 01; 10(23):3459-63. PubMed ID: 15526365
    [Abstract] [Full Text] [Related]

  • 50. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.
    Battle TE, Arbiser J, Frank DA.
    Blood; 2005 Jul 15; 106(2):690-7. PubMed ID: 15802533
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER, Arlotti JA, Marynowski SW, Singh SV.
    Clin Cancer Res; 2008 Feb 15; 14(4):1248-57. PubMed ID: 18281560
    [Abstract] [Full Text] [Related]

  • 54. Multifunctional effects of honokiol as an anti-inflammatory and anti-cancer drug in human oral squamous cancer cells and xenograft.
    Cho JH, Jeon YJ, Park SM, Shin JC, Lee TH, Jung S, Park H, Ryu J, Chen H, Dong Z, Shim JH, Chae JI.
    Biomaterials; 2015 Feb 15; 53():274-84. PubMed ID: 25890726
    [Abstract] [Full Text] [Related]

  • 55. The therapeutic potential of epigallocatechin‑3‑gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study.
    Yoshimura H, Yoshida H, Matsuda S, Ryoke T, Ohta K, Ohmori M, Yamamoto S, Kiyoshima T, Kobayashi M, Sano K.
    Mol Med Rep; 2019 Aug 15; 20(2):1139-1148. PubMed ID: 31173211
    [Abstract] [Full Text] [Related]

  • 56. Role of transcription factor Sp1 in the 4-O-methylhonokiol-mediated apoptotic effect on oral squamous cancer cells and xenograft.
    Cho JH, Lee RH, Jeon YJ, Shin JC, Park SM, Choi NJ, Seo KS, Yoon G, Cho SS, Kim KH, Cho JJ, Cho YS, Kim DH, Hong JT, Lee TH, Park HJ, Jung S, Seo JM, Chen H, Dong Z, Chae JI, Shim JH.
    Int J Biochem Cell Biol; 2015 Jul 15; 64():287-97. PubMed ID: 25982202
    [Abstract] [Full Text] [Related]

  • 57. Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia.
    Zhou B, Li H, Xing C, Ye H, Feng J, Wu J, Lu Z, Fang J, Gao S.
    Biochem Pharmacol; 2017 Mar 15; 128():12-25. PubMed ID: 28043811
    [Abstract] [Full Text] [Related]

  • 58. Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells.
    Wang Y, Yang Z, Zhao X.
    Toxicol Mech Methods; 2010 Jun 15; 20(5):234-41. PubMed ID: 20374036
    [Abstract] [Full Text] [Related]

  • 59. Magnolol's Therapeutic Efficacy and Immunomodulatory Effects in Oral Squamous Cell Carcinoma.
    Tseng CF, Chen HM, Liao TL, Hsu FT, Yeh CJ, Chen WT, Kok SH.
    In Vivo; 2024 Jun 15; 38(5):2152-2164. PubMed ID: 39187336
    [Abstract] [Full Text] [Related]

  • 60. Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy.
    Ling B, Liang SF, Xu YH, Zhao XY, Tang MH, Liu XY, Zhao X, Huang CH, Chen LJ, Wei YQ.
    Amino Acids; 2008 Jun 15; 35(1):115-22. PubMed ID: 18157584
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.